Ye Tian

机构：Huazhong University of Science and Technology · ORCID：0000-0001-6080-1289

发表论文 74 篇 · 总被引 1286 次 · h-index 18

代表论文

• Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis (2022 · Chinese Medical Journal · 被引 53)
• The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma (2022 · Cell Death and Disease · 被引 25)
• Penpulimab combined with anlotinib in patients with R/M HNSCC after failure of platinum-based chemotherapy: a single-arm, multicenter, phase Ⅱ study (2023 · ESMO Open · 被引 13)
• Evaluating the toxicity profile of combination immune checkpoint inhibitors: a disproportionality analysis of real-world adverse events from the FDA Adverse Event Reporting System for tremelimumab, durvalumab, ipilimumab, and nivolumab (2025 · Frontiers in Immunology · 被引 11)
• ROS-responsive ADPH nanoparticles for image-guided surgery (2023 · Frontiers in Chemistry · 被引 8)
• ATP6AP1 is a potential prognostic biomarker and is associated with iron metabolism in breast cancer (2022 · Frontiers in Genetics · 被引 8)